Taken together, we demonstrate that the combination of radiation and HMGB1 inhibition results in attenuation of pro-tumor immune mechanisms within the tumor immune microenvironment by decreasing the frequency of immunosuppressive cells. The gene discussed is HMGB1; the disease is neoplasm.